Sangamo Biosciences (SGMO) Tops Q3 EPS by 12c

Sangamo Biosciences (NASDAQ: SGMO) reported Q3 EPS of ($0.13), $0.12 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $8.6 million versus the consensus estimate of $13.09 million.

For earnings history and earnings-related data on Sangamo Biosciences (SGMO) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike
• Barclays says AI trade is maturing, favors greater diversification